<DOC>
	<DOCNO>NCT01820052</DOCNO>
	<brief_summary>Fibromyalgia ( FM ) disorder chronic widespread musculoskeletal pain alternative cause identify . The condition often accompany feature fatigue , stiffness , cold intolerance , cognitive impairment , intolerance external stimulus , sleep disturbance , anxiety depression , significantly affect quality life . Fibromyalgia characterize altered pain perception , study show fibromyalgia prevalent patient iron deficiency anemia . Iron essential number enzyme involve serotonin dopamine synthesis . Deficiency serotonergic neuronal functioning might relate pathophysiology FM . This study attempt explore use oral iron cheap readily available alternative treatment FM .</brief_summary>
	<brief_title>A Randomized Trial Oral Iron Therapy Fibromyalgia</brief_title>
	<detailed_description>Fibromyalgia ( FM ) disorder chronic widespread musculoskeletal pain alternative cause identify . The condition often accompany feature fatigue , stiffness , cold intolerance , cognitive impairment , intolerance external stimulus , sleep disturbance , anxiety depression , significantly affect quality life . Fibromyalgia characterize altered pain perception , study show fibromyalgia prevalent patient iron deficiency anemia . Iron essential number enzyme involve serotonin dopamine synthesis . Deficiency serotonergic neuronal functioning might relate pathophysiology FM . A dysregulation dopaminergic transmission pathophysiology FM also suggest . This bring forth postulation iron cofactor serotonin dopamine production may role etiology FM . A number therapy currently vogue FM , pharmacological non-pharmacological . Drugs show effective FM include tricyclic antidepressant ( amitryptiline , cyclobenzaprine ) , dual reuptake inhibitor ( duloxetine , milnacipran ) alpha-2-delta ligand ( pregabalin , gabapentin ) . However cost major factor , often treatment result disappointing . Hence investigator plan conduct randomized control trial iron therapy fibromyalgia . IF proven , iron could cheap easily available alternative treatment common often disabling condition . Materials method : Patients FM attend OPD Department Clinical Immunology identify . Diagnosis shall make per ACR 2010 preliminary diagnostic criterion fibromyalgia measurement symptom severity . After seek informed consent , subject undergo baseline investigation look Hb , thyroid function test 25-OH-Vitamin . Patients Hb &lt; 8 g hypothyroidism , deficiency Vitamin D connective tissue disease exclude study . Patients baseline FIQ &gt; 40 take study . Baseline depression assess use BPHQ patient baseline BPHQ &gt; 4 exclude study . Following , patient undergo assessment serum ferritin baseline , irrespective serum ferritin level , randomize 2 group . Target sample size group 60 . The group blind patient investigator , allocation concealment maintain use pre-sealed envelope drug packet . Group A receive standard care treatment fibromyalgia ( Amitryptiline 25 mg/day , Duloxetine upto 60 mg/day , Pregabalin upto 300 mg/day either singly combination ) along placebo 3 month . Group B receive standard care treatment fibromyalgia ( Amitryptiline upto 25 mg/day , Duloxetine upto 60 mg/day , Pregabalin 300 mg/day either singly combination ) along 230 mg oral elemental iron daily 3 month . Assessment baseline 3 month do respect primary end point - Widespread Pain Index ( WPI ) , Symptom Severity Scale score ( SSS ) , Hindi version Fibromyalgia Impact Questionnaire ( FIQ ) , secondary end point - Visual Analog Scale pain ( VAS ) , Hindi version Brief Physical Health Questionnaire ( BPHQ ) , Hindi version SF-36 questionnaire . Patients monitor side effect oral iron therapy ( nausea , vomit , gastrointestinal irritation , constipation , diarrhea ) . At end 3 month , statistical analysis do determine significance difference placebo group A B respect mention end point . Patients change FIQ &gt; 25 % take responder . The change level various end point , viz . WPI , SSS , VAS , BPHQ , SF-36 secondary consideration . Significance : This study attempt explore use oral iron cheap readily available alternative treatment FM .</detailed_description>
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Iron</mesh_term>
	<criteria>Patients Fibromyalgia fulfil ACR 2010 criterion . Patients baseline FIQ &gt; 40 take study . Patients Hb &lt; 8 g hypothyroidism , deficiency Vitamin D connective tissue disease exclude study . Baseline depression assess use BPHQ patient baseline BPHQ &gt; 4 exclude study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Fibromyalgia</keyword>
</DOC>